Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Equities
2315
CNE100005D27
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.83 CNY | +0.82% | +11.96% | -17.95% |
May. 06 | Biocytogen Enters into Evaluation and Potential Licensing Agreement with Biocopy for TCR-mimic Antibodies | CI |
Apr. 26 | Biocytogen Pharmaceuticals' Loss Narrows in 2023 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.95% | 498M | |
+26.98% | 44.96B | |
-0.66% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.44% | 26.08B | |
-21.37% | 19.03B | |
+5.99% | 12.75B | |
+27.85% | 12.06B | |
-3.21% | 11.75B |
- Stock Market
- Equities
- 2315 Stock
- News Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Biocytogen Pharmaceuticals' Loss Narrows in 2023